QTTB Similar Chart Price Prediction
The price of QTTB is predicted to go up 0.26%, based on the high correlation periods with COOT. The similarity of these two price pattern on the periods is 99.78%.
QTTB
COOT
Up: 0.26%Similarity: 99.78%
QTTB Revenue Forecast
QTTB EPS Forecast
QTTB FAQs
What is bull’s view on QTTB?
What is bear's view on QTTB?
QTTB Analyst's Forecast
Yatin Suneja
Guggenheim
Strong Buy → Hold
Price Target
n/a
Upside
0%
As previously reported, Guggenheim downgraded Q32 Bio to Neutral from Buy and removed the firm's prior price target following the announcement of "disappointing" topline results from bempikibart's Phase 2 studies in atopic dermatitis and alopecia areata. Though Q32 plans to move forward in AA by enrolling 20 additional patients with a loading dose regimen in the Part B expansion, based on the totality of data, the firm says it has "limited hope" for the applicability of this mechanism of action in AA.
Jay Olson
Oppenheimer
Buy
Price Target
$80 → $20
Upside
+236.13%
Christopher Raymond
Piper Sandler
Buy
Price Target
$85 → $20
Upside
+236.13%